FLAMMA is a family owned & run, award winning, fully integrated CDMO with Headquarters located near Milan, Italy. FLAMMA specializes in the cGMP manufacturing of small molecule APIs, NCEs, RSMs & advanced intermediates. FLAMMA has significant expertise in high value chiral materials (specifically amino acid related materials used
read morein peptide drugs). FLAMMA provides manufacturing options for the entire life cycle of a small molecule drug. FLAMMA can provide assistance for early stage pre-clinical development (from g to kg using our facility located outside of Philadelphia in the USA) to large-scale commercial manufacturing (from 100’s of kg to MT) at one of our three facilities located in Italy. FLAMMA’s 100% owned and self-managed facility in Dalian, China allows one to leverage its offerings to provide a stable and secure supply chain. For those interested in IC4C In China For China) API supply, Flamma Honkai is a viable option to consider. With 800 employees and a total capacity of 1,100 m3 (900 m3 in Italy and 200 m3 in China), learn why FLAMMA is a preferred supplier to the pharmaceutical and biotech industry. Visit FlammaGroup.com for further information.